Endotracheal Aerosolization Device for Laboratory Investigation of Pulmonary Delivery of Nanoparticle Suspensions: In Vitro and in Vivo Validation.

MLA

Huang, Zhengwei, et al. “Endotracheal Aerosolization Device for Laboratory Investigation of Pulmonary Delivery of Nanoparticle Suspensions: In Vitro and in Vivo Validation.” Molecular Pharmaceutics, vol. 15, no. 12, Dec. 2018, pp. 5521–33. EBSCOhost, https://doi.org/10.1021/acs.molpharmaceut.8b00668.

APA

Huang, Z., Huang, Y., Ma, C., Ma, X., Zhang, X., Lin, L., Zhao, Z., Pan, X., & Wu, C. (2018). Endotracheal Aerosolization Device for Laboratory Investigation of Pulmonary Delivery of Nanoparticle Suspensions: In Vitro and in Vivo Validation. Molecular Pharmaceutics, 15(12), 5521–5533. https://doi.org/10.1021/acs.molpharmaceut.8b00668

Chicago

Huang, Zhengwei, Ying Huang, Cheng Ma, Xiangyu Ma, Xuejuan Zhang, Ling Lin, Ziyu Zhao, Xin Pan, and Chuanbin Wu. 2018. “Endotracheal Aerosolization Device for Laboratory Investigation of Pulmonary Delivery of Nanoparticle Suspensions: In Vitro and in Vivo Validation.” Molecular Pharmaceutics 15 (12): 5521–33. doi:10.1021/acs.molpharmaceut.8b00668.